| Members |
targetComponentId |
| neurofibramatos 3 |
Schwannomatosis |
| neurofibrom |
Benign neurofibroma |
| neurofibromatos typ 3 |
Schwannomatosis |
| Neuroleptic malignant syndrome |
Neuroleptic malignant syndrome |
| Neurologic myelopathy-retired |
Spinal cord disorder (disorder) |
| neurologisk sjukdom orsakad av intagbar alkohol |
Neurological disorder caused by ethanol (disorder) |
| Neurological status not worse than preoperative baseline |
Neurological status is consistent with or improved from preoperative baseline (finding) |
| Neurolysis - action |
Destruction - action |
| Neuroma (excl. acoustic) |
Neuroma (disorder) |
| neurom (exklusive akustikusneurinom) |
Neuroma (morphologic abnormality) |
| neurom, kategori |
Neuroma (morphologic abnormality) |
| neurom |
Neuroma (morphologic abnormality) |
| neuromuskulär diagnostisk åtgärd |
Neuromuscular procedure |
| Neuromyositis-retired |
Polymyositis |
| neuropatisk impotens |
Erectile dysfunction due to neuropathy |
| Neuroses or other mental disorder NOS |
Mental disorder |
| Neurotic, personality and other nonpsychotic disorders |
Mental disorder |
| Neurovascular island sensory skin flap NEC |
Neurovascular island sensory skin flap |
| neutralt adrenalin 0,05 %, ögondroppar |
Adrenaline (as adrenaline acid tartrate) 500 microgram/mL eye solution |
| neutralt adrenalin 0,1 %, ögondroppar |
Adrenaline 1 mg/mL eye solution |
| neutralt adrenalin 0,25 %, ögondroppar |
Adrenaline 2.5 mg/mL eye solution |
| neutralt adrenalin 0,5 %, ögondroppar |
Adrenaline (as adrenaline acid tartrate) 500 microgram/mL eye solution |
| Neutron |
Neutron |
| Nevirapine 50mg/5mL suspension |
Product containing precisely nevirapine 10 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| färsk partiell retinalavlossning med multipla defekter |
Partial detachment of retina with multiple breaks of retina (disorder) |
| ny sexuell kontakt |
New sexual contact (finding) |
| Newborn physiological jaundice NOS |
Newborn physiological jaundice |
| nikardipinhydroklorid 60 mg, kapsel med modifierad frisättning |
Nicardipine only product in oral dose form |
| nikardipinhydroklorid 60 mg, depåkapsel |
Nicardipine only product in oral dose form |
| Nicardipine m/r capsule |
Nicardipine only product in oral dose form |
| Nicotine 10mg inhalator refill pack |
Nicotine only product |
| Nicotine 10mg inhalator starter pack |
Nicotine only product |
| nikotin 10 mg, inhalationsånga, vätska |
Nicotine only product |
| nikotin 11 mg/24 timmar, depåplåster |
Nicotine 458 microgram/hour prolonged-release transdermal patch |
| nikotin 22 mg/dygn, depåplåster |
Product containing precisely nicotine 917 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
| nikotinberoende med nuvarande användning |
Nicotine dependence (disorder) |
| gratis behandling med nikotinersättning |
Nicotine replacement therapy |
| Nicotine replacement therapy provided free |
Nicotine replacement therapy |
| Nicotine replacement therapy provided free |
Nicotine replacement therapy |
| Nicotine stomatitis |
Leukokeratosis nicotina palati |
| nikotinsyra tablett 375 mg med modifierad frisättning, nikotinsyra tablett 500 mg med modifierad frisättning och nikotinsyra tablett 750 mg med modifierad frisättning, upptrappningsförpackning |
Nicotinic acid only product in oral dose form |
| niacin 375 mg, depåtablett |
Nicotinic acid only product in oral dose form |
| nifedipin 90 mg, tablett med modifierad frisättning |
Product containing only nifedipine in oral dose form (medicinal product form) |
| nifedipin 90 mg, depåtablett |
Product containing only nifedipine in oral dose form (medicinal product form) |
| nimodipin 200 mikrogram/ml, infusionsvätska, lösning, injektionsflaska 50 ml |
Product containing precisely nimodipine 200 microgram/1 milliliter conventional release solution for injection (clinical drug) |
| nisoldipin 40 mg, tablett med modifierad frisättning |
Nisoldipine only product in oral dose form |
| nisoldipin 40 mg, depåtablett |
Nisoldipine only product in oral dose form |
| nitroderivat och aminoderivat av bensen och bensenhomologer |
Benzene derivative hydrocarbon |
| Nitroglycerin 2.5mg |
Glyceryl trinitrate 2.5 mg oral capsule |
| inget rörelseomfång i fotled vid aktiv extension |
No active range of ankle plantar flexion (finding) |
| inget rörelseomfång i fotled vid aktiv flexion |
No active range of ankle dorsiflexion (finding) |
| ingen diagnos på axel 1 |
Psychological finding |
| ingen diagnos på axel 2 |
Psychological finding |
| ingen diagnos på axel 3 |
Psychological finding |
| ingen diagnos på axel 4 |
Psychological finding |
| ingen diagnos på axel 5 |
Psychological finding |
| inga kända allergier |
No known allergy (situation) |
| No living organism identified |
No living organism identified (finding) |
| ingen patologisk T-kategori, otillräcklig mängd vävnad (prostata) |
American Joint Committee on Cancer pT2 (qualifier value) |
| inget rörelseomfång i fotled vid passiv extension |
No passive range of ankle plantar flexion |
| inget rörelseomfång i fotled vid passiv flexion |
No passive range of ankle dorsiflexion (finding) |
| ingen tidigare anamnes på djurallergi |
No known animal allergy (situation) |
| No stain |
No stain applied |
| Nocardia amarae |
Gordonia amarae (organism) |
| Nocardia autotrophica |
Pseudonocardia autotrophica |
| Nocardia brevicatena-komplex |
Nocardia brevicatena-paucivorans complex (organism) |
| Nocardia corynebacterioides |
Rhodococcus corynebacterioides (organism) |
| Nocardia mediterranei |
Amycolatopsis mediterranei |
| Nocardia orientalis |
Amycolatopsis orientalis (organism) |
| Nocardia rugosa |
Amycolatopsis rugosa |
| Nocardia simplex |
Pimelobacter simplex (organism) |
| Nocardia sulphurea |
Amycolatopsis sulphurea |
| Nocardioides simplex |
Pimelobacter simplex (organism) |
| Nocardiopsis africana |
Nonomuraea africana (organism) |
| Nocardiopsis antarcticus |
Nocardiopsis dassonvillei |
| Nocardiopsis coeruleofusca |
Saccharothrix coeruleofusca |
| Nocardiopsis dassonvillei subspecies prasina |
Nocardiopsis prasina |
| Nocardiopsis flava |
Lechevalieria flava (organism) |
| Nocardiopsis longispora |
Saccharothrix longispora |
| lymfknuteengagemang i stadium N1a |
American Joint Committee on Cancer cN1a (qualifier value) |
| lymfknuteengagemang i stadium N1b |
American Joint Committee on Cancer cN1b (qualifier value) |
| lymfknuteengagemang i stadium N2a |
American Joint Committee on Cancer cN2a (qualifier value) |
| lymfknuteengagemang i stadium N2b |
cN2b |
| lymfknuteengagemang i stadium N2c |
cN2c |
| Nodular (qualifier value) |
Monthly |
| Nodular |
Nodule |
| nodulärt lymfom, extranodalt och/eller organlokaliserat |
Nodular lymphoma (disorder) |
| Nodular tenosynovitis |
Nodular tenosynovitis |
| bullrig miljö |
Noisy environment (finding) |
| icke-allergisk purpura |
Purpuric disorder (disorder) |
| non-A-non-B-non-C-hepatit |
Viral hepatitis |
| non-Hodgkin-lymfom, kategori |
Non-Hodgkin lymphoma |
| malignt non-Hodgkin-lymfom |
Non-Hodgkin lymphoma |
| Non-accidental injury to adult |
Non-accidental injury to adult |
| pseudoallergi mot substans |
Non-allergic hypersensitivity disposition |
| Non-arthropod-borne viral disease |
Viral disease |
| Non-coronary arterial angiography |
Angiography of artery |
| Non-depolarizing muscle relaxant |
Product containing nondepolarizing neuromuscular blocker (product) |
| Non-domestic mammal |
Class Mammalia (organism) |
| icke-läkande operationssår |
Non-healing surgical wound (finding) |
| Non-immune anticoagulant disorder |
Blood coagulation disorder |
FHIR